Taking steps towards reducing osteoporosis in Duchenne muscular dystrophy

Affiliations

¹ Division of Endocrinology, Department of Pediatrics, Stanford University Medical Center, Room S302, 300 Pasteur Drive, Stanford, CA 94305-5208, USA. lkbach@stanford.edu

Review

Laura K Bachrach. Neuromuscul Disord. 2005 Jan.

. 2005 Jan;15(1):86-7.

doi: 10.1016/j.nmd.2004.10.011. Epub 2004 Nov 26.

¹ Division of Endocrinology, Department of Pediatrics, Stanford University Medical Center, Room S302, 300 Pasteur Drive, Stanford, CA 94305-5208, USA. lkbach@stanford.edu

No abstract available

Comment on

Report of a Muscular Dystrophy Campaign funded workshop Birmingham, UK, January 16th 2004. Osteoporosis in Duchenne muscular dystrophy; its prevalence, treatment and prevention.
Quinlivan R, Roper H, Davie M, Shaw NJ, McDonagh J, Bushby K. Quinlivan R, et al. Neuromuscul Disord. 2005 Jan;15(1):72-9. doi: 10.1016/j.nmd.2004.09.009. Epub 2004 Dec 10. Neuromuscul Disord. 2005. PMID: 15639124 No abstract available.
Bone health in Duchenne muscular dystrophy: a workshop report from the meeting in Cincinnati, Ohio, July 8, 2004.
Biggar WD, Bachrach LK, Henderson RC, Kalkwarf H, Plotkin H, Wong BL. Biggar WD, et al. Neuromuscul Disord. 2005 Jan;15(1):80-5. doi: 10.1016/j.nmd.2004.09.010. Neuromuscul Disord. 2005. PMID: 15639125 No abstract available.